Best PET-CT with Gallium 68 (DOTA) Doctors in Istanbul, Turkey — TOP 48

Professor Kezban Berberoglu is a nuclear medicine specialist at Anadolu Medical Center. She completed advanced radiology training at the Johns Hopkins University School of Medicine.

• Specializes in PET-CT with Gallium 68 for neuroendocrine and prostate cancers
• Expert in targeting cancer cells using Lutetium-177 and Actinium-225 therapies
• Completed specialized PET/CT and SPECT/CT imaging training at Johns Hopkins
• Member of the European Association of Nuclear Medicine (EANM)
• Serves on the oncology work group for the Turkish Society of Nuclear Medicine

Professor Bulent Karagoz is a medical oncologist who formerly led the Internal Diseases Department at Istanbul Okan University.

• Treats neuroendocrine tumors often assessed with PET-CT Gallium 68 (DOTA) imaging
• Specializes in tumor biology to understand how specific molecules help cancer grow
• Authored over 40 scientific publications focused on tumor immunology and immunotherapy
• Member of the European Head and Neck Society and Turkish Medical Oncology Association
• Uses targeted therapies to attack cancer at a molecular level

Dr. Ilker Tinay leads urological oncology at Anadolu Medical Center. He uses PET-CT with Gallium 68 to provide highly accurate staging for urological cancers.

• Specializes in Gallium 68 PSMA and DOTATATE imaging for prostate and kidney diseases
• Serves as an Executive Board Member of the Association of Urooncology
• Fellow of the American College of Surgeons – a mark of high surgical standards
• Received the Scientific Research Award from the Urooncology Association for his oncology work
• Secretary of the Bladder Tumors Research Group within the Association of Urooncology

Dr. Tamer Aksoy is a nuclear medicine specialist at Hisar Hospital Intercontinental in Istanbul. He specializes in PET/CT examinations and radionuclide therapies. Dr. Aksoy completed clinical research as an observer at the Netherlands Cancer Institute in Amsterdam. He holds the title of Associate Professor.

• Member of the European Association of Nuclear Medicine.
• Expert in PET/CT imaging using Gallium 68 for precise diagnostics.
• Focuses on radionuclide therapy for oncology patients.
• Works at Hisar Hospital, which holds JCI accreditation for safety and quality.

Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.

• Member of the European Society for Medical Oncology (ESMO).
• Active member of the American Society of Clinical Oncology (ASCO).
• Member of the European Neuroendocrine Tumor Society (ENETS).
• Works at JCI-accredited facility with advanced PET-MRI and radiology departments.

Dr. Ayshe Okumush is a radiation oncologist at Private NeoLife Medical Center. She earned her MD from Karadeniz Technical University in 2003. She completed a residency in radiation oncology at Sisli Etfal Training and Research Hospital from 2006 to 2011.

She served as a specialist at Diyarbakir Uckuyular Training and Research Hospital from 2011 to 2013 and at Sisli Etfal from 2013 to 2016. She then worked at Yeni Yuzyil University Private Gaziosmanpasa Hospital from 2016 to 2026. She joined NeoLife in 2026.

Memberships: Turkish Society for Radiation Oncology (TROD) and the European Society for Radiotherapy and Oncology (ESTRO). Clinical focus: SRS, SRT, SBRT; VMAT, IMRT; radiotherapy for head and neck, lung, and brain tumors; SGRT, TBI, and 3D brachytherapy.

Dr. Sefik Igdem is a radiation oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating head, neck, and prostate cancers. He currently serves as a Professor at Demiroğlu Bilim University. Dr. Igdem uses Truebeam STx and Halcyon systems for accurate radiotherapy.

• Specializes in conformal treatments for complex tumor cases.
• Treats various conditions including lung, breast, and brain tumors.
• Practices at a JCI-accredited hospital that serves 200,000 patients annually.
• Completed his radiation oncology training at the Istanbul University Cerrahpaşa Faculty.

Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.

He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).

Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).

Dr. Mustafa Solak completed an advanced oncology fellowship at the MD Anderson Cancer Center in the USA. For patients needing PET-CT with Gallium 68, he provides expert interpretation for staging complex gastrointestinal and neuroendocrine tumors.

• Specializes in systemic therapies for breast, lung, and gastrointestinal cancers
• Fellowship graduate of the Hacettepe University Cancer Institute
• Oversees immunotherapy and targeted treatments for advanced stages of disease
• Provides radioiodine therapy for thyroid disorders at Hisar Hospital

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center. He uses PET-CT with Gallium 68 (DOTA) to identify neuroendocrine tumors and guide systemic therapies.

• Trained at Istanbul University Cerrahpaşa, one of the nation's top medical schools
• Former oncology expert at Gülhane Military Medical Academy
• Specialist in internal medicine and medical oncology
• Member of the Turkish Medical Oncology Society
• Uses immunotherapy and targeted therapy for various cancer types

Dr. Gorkem Turkkan is a radiation oncologist at Hisar Hospital Intercontinental in Istanbul. He has successfully completed over 2,500 radiotherapy sessions using MR-Linac technology. Dr. Turkkan focuses on MRI-guided radiotherapy and stereotactic treatments for various cancers. He conducted clinical research on proton therapy at the MAASTRO Clinic in the Netherlands.

• Specializes in prostate, breast, lung, and head and neck cancer treatments.
• Uses VMAT and IMRT techniques to target tumors with precision.
• Maintains membership in the European Society of Radiotherapy and Oncology.
• Works at a JCI-accredited hospital serving 500,000+ patients annually.

Dr. Aksoy is an Assistant Professor at Istanbul University Cerrahpaşa Medical Faculty. He leads specialized imaging at Hisar Intercontinental Hospital, including PET-CT with Gallium 68.

• Expert in interventional radiology – uses imaging to perform precise, minimally invasive procedures
• Member of the European Society of Radiology and the International Society of Radiology
• Specializes in whole-body imaging – identifies tumors and spread throughout the body
• Contributed academic research to 13 national and international medical congresses

Assoc. Prof. Dr. Heves Sürmeli is a specialist in Internal Medicine and Medical Oncology. She received her medical degree (M.D.) from Eskişehir Osmangazi University in 2004. She completed her Internal Medicine residency at Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul (2005–2010). She then completed subspecialty training in Medical Oncology at the same hospital (2014–2017).

At the same center, she served as a Medical Oncology Specialist (2017–2023). She then worked as Administrative and Clinical Director (2023–2026). Her clinical interests include breast, lung, gynecologic, gastrointestinal, and urologic cancers.

She has published many articles in international peer‑reviewed journals. She has presented at national and international conferences. She is active in professional societies. She has received several awards.

Prof. Seref Komurcu is an ESMO-certified oncologist at Anadolu Medical Center. He uses PET-CT with Gallium 68 to find and treat neuroendocrine tumors.

• Holds ECFMG certification – meeting the high medical education standards of the USA
• Authored over 110 scientific papers on tumor detection and treatment
• Member of ASCO – the world leading body for clinical oncology professionals
• Former Professor at Gulhane Military Medical Academy – trained the next generation of specialists
• Specializes in systemic therapies for complex cancers – including pancreatic and adrenal tumors

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Dr. Sezer Saglam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating gastrointestinal and breast cancers. His research on rectal cancer timing has influenced global treatment protocols. Dr. Saglam develops personalized therapy plans using targeted medicine and precision techniques.

• Nominated for the International Best Researcher Award for work on liver cancer.
• Leads clinical trials focused on targeted therapies and precision oncology.
• Member of the American Society of Clinical Oncology (ASCO).
• Certified by the European Society for Medical Oncology (ESMO).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

• Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
• Treats patients at a JCI-accredited hospital in Istanbul.
• Performs staging and biopsies for liver, lung, and pancreatic tumors.
• Provides targeted immunotherapy using medications like Keytruda.